Skanska signs additional contract for biotechnology facility in Charlottesville, USA, for USD 66M, about SEK 690M
Skanska (SKBSY) has secured an additional contract worth USD 66 million (SEK 690M) with the University of Virginia for the Paul and Diane Manning Institute of Biotechnology construction project. The five-story, 354,000-square-foot state-of-the-art facility will be located at Fontaine Research Park in Charlottesville, Virginia.
The facility will feature modular laboratory space, expanded research facilities, and core facilities, accommodating 100-150 researchers and biotechnology companies. Construction commenced in December 2023, with completion expected in Q4 2027. The contract value will be included in US order bookings for Q2 2025.
Skanska (SKBSY) ha ottenuto un ulteriore contratto del valore di 66 milioni di dollari USA (690 milioni di SEK) con l'Università della Virginia per il progetto di costruzione del Paul and Diane Manning Institute of Biotechnology. La struttura all'avanguardia di cinque piani e 354.000 piedi quadrati sarà situata al Fontaine Research Park di Charlottesville, Virginia.
La struttura includerà spazi modulari per laboratori, aree di ricerca ampliate e strutture core, ospitando tra 100 e 150 ricercatori e aziende biotecnologiche. I lavori sono iniziati a dicembre 2023 e la conclusione è prevista per il quarto trimestre del 2027. Il valore del contratto sarà incluso nelle prenotazioni ordini USA per il secondo trimestre 2025.
Skanska (SKBSY) ha asegurado un contrato adicional por un valor de 66 millones de dólares (690 millones de SEK) con la Universidad de Virginia para el proyecto de construcción del Paul and Diane Manning Institute of Biotechnology. La instalación de última generación de cinco pisos y 354,000 pies cuadrados estará ubicada en Fontaine Research Park en Charlottesville, Virginia.
La instalación contará con espacios modulares para laboratorios, instalaciones de investigación ampliadas y áreas centrales, acomodando a 100-150 investigadores y empresas biotecnológicas. La construcción comenzó en diciembre de 2023 y se espera que finalice en el cuarto trimestre de 2027. El valor del contrato se incluirá en las reservas de pedidos de EE.UU. para el segundo trimestre de 2025.
스칸스카(SKBSY)는 버지니아 대학교와 6600만 달러(690백만 SEK) 규모의 추가 계약을 체결하여 Paul and Diane Manning 생명공학 연구소 건설 프로젝트를 진행하게 되었습니다. 이 최첨단 5층, 354,000평방피트 규모의 시설은 버지니아 주 샬러츠빌의 폰테인 연구 공원에 위치할 예정입니다.
이 시설은 모듈형 실험실 공간, 확장된 연구 시설 및 핵심 시설을 갖추어 100~150명의 연구원과 생명공학 기업들을 수용할 예정입니다. 건설은 2023년 12월에 시작되었으며, 2027년 4분기에 완공될 예정입니다. 계약 금액은 2025년 2분기 미국 수주 실적에 포함될 것입니다.
Skanska (SKBSY) a obtenu un contrat supplémentaire d'une valeur de 66 millions de dollars US (690 millions de SEK) avec l'Université de Virginie pour le projet de construction de l'Institut de biotechnologie Paul et Diane Manning. Ce bâtiment ultramoderne de cinq étages et de 354 000 pieds carrés sera situé au Fontaine Research Park à Charlottesville, en Virginie.
Le bâtiment comprendra des espaces modulaires pour laboratoires, des installations de recherche étendues ainsi que des installations centrales, accueillant entre 100 et 150 chercheurs et entreprises de biotechnologie. La construction a débuté en décembre 2023 et devrait s'achever au quatrième trimestre 2027. La valeur du contrat sera intégrée aux commandes enregistrées aux États-Unis au deuxième trimestre 2025.
Skanska (SKBSY) hat einen weiteren Auftrag im Wert von 66 Millionen US-Dollar (690 Mio. SEK) von der University of Virginia für das Bauprojekt des Paul and Diane Manning Institute of Biotechnology erhalten. Die hochmoderne, fünfstöckige Einrichtung mit 354.000 Quadratfuß wird im Fontaine Research Park in Charlottesville, Virginia, errichtet.
Die Einrichtung wird modulare Laborflächen, erweiterte Forschungseinrichtungen und Kernbereiche bieten und Platz für 100-150 Forscher sowie Biotechnologieunternehmen schaffen. Der Baubeginn war im Dezember 2023, die Fertigstellung ist für das vierte Quartal 2027 geplant. Der Vertragswert wird in den US-Auftragsbestellungen für das zweite Quartal 2025 enthalten sein.
- Secured additional USD 66M contract, strengthening order backlog
- Project contributes to long-term revenue visibility through 2027
- Strategic partnership with prestigious University of Virginia enhances reputation in biotech construction
- None.
Upon completion, the five-story, approximately 33,000 square meter (354,000-square-foot) Paul and Diane Manning Institute of Biotechnology at the University of
The building will include modular, multi-use laboratory space and support space, expanded research facilities, core facilities and an area for 100-150 researchers and partnering biotechnology companies to foster collaboration on the frontlines of science and technology.
Construction began in December 2023 and is expected to be completed in the fourth quarter of 2027.
For further information please contact:
Ashley Jeffery, Communications Manager,
Andreas Joons, Press Officer, Skanska Group, tel +46 76 870 75 51
Direct line for media, tel +46 (0)10 448 88 99
This and previous releases can also be found at www.skanska.com.
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
20250520 US additional contract UVA BioTech | |
https://news.cision.com/skanska/i/image---biotech-charlottesville,c3410996 | Image - Biotech Charlottesville |
View original content:https://www.prnewswire.com/news-releases/skanska-signs-additional-contract-for-biotechnology-facility-in-charlottesville-usa-for-usd-66m-about-sek-690m-302460011.html
SOURCE Skanska
FAQ
What is the value of Skanska's new contract for the UVA biotechnology facility?
When will Skanska complete the UVA biotechnology facility construction?
How large is the UVA biotechnology facility being built by Skanska?
How many researchers will the new UVA biotechnology facility accommodate?
When will SKBSY record this contract in their order bookings?
